Recently, more attention has been devoted to the classification of primary breast cancer into molecular subtypes using markers like estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor (HER) [3,4]. This evidence concerns the gene ESR1 and breast cancer.